Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A ...

Masimo Corporation’s MASI share price has dipped by 8.86%, which has investors questioning if this is right time to buy.

No confirmation if it was a ransomware attack yet, but parts of Masimo infrastructure were shut down to contain the incident.

Masimo SET ® Measure-through Motion and Low Perfusion ™ pulse oximetry, introduced in 1995 ... when used for continuous monitoring with Masimo Patient SafetyNet ™ in post-surgical wards ...

Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 24.5% year on year to $372 million. The company expects the full ...

Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on ... Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation ...

Masimo is a US-based medical technology company that develops noninvasive monitoring solutions like pulse oximetry and brain function monitoring. Healthcare organizations are often the targets of ...

MASI), a medical device company that manufactures and sells a variety of non-invasive patient monitoring technologies. Masimo is the market leader in pulse oximetry, which measures oxygen ...

Masimo is focusing on AI-based innovations in healthcare monitoring. Masimo showcased ... particularly in pulse oximetry. Masimo reported an EPS of $1.36, outperforming the consensus forecast ...

And welcome to Masimo's First Quarter ... to leverage our leadership position in pulse oximetry to strengthen our patient impact across our advanced monitoring categories, including Capnography ...